Trulance® Safety Indicated for adult patients with IBS-C and CIC. ISI below.

TRULANCE® for IBS-C

Therapy for adult patients with IBS-C

Access indication details, ISI, and counseling tools to support adults using TRULANCE for irritable bowel syndrome with constipation.

Indication

TRULANCE is indicated for treatment of adults with IBS-C

Counsel patients on expected benefits, potential adverse reactions, and the importance of following prescribing directions.

Patient education
  • Most common adverse reaction is diarrhea; instruct patients to contact their healthcare provider if severe.
  • Confirm adult status and absence of mechanical GI obstruction prior to treatment.
  • Encourage ongoing communication about symptom changes and tolerability.
Reminder: TRULANCE is contraindicated in patients less than 6 years of age and in patients with known or suspected mechanical gastrointestinal obstruction. Avoid use in pediatric patients; safety and efficacy have not been established in patients under 18.